Published in Eur J Neurol on August 01, 2007
HLA B*44: protective effects in MS susceptibility and MRI outcome measures. Neurology (2010) 2.29
The immunogenetics of multiple sclerosis. Immunogenetics (2008) 1.04
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies. Neurol Genet (2016) 0.97
Does narcolepsy symptom severity vary according to HLA-DQB1*0602 allele status? Sleep (2010) 0.94
Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis. Mult Scler (2013) 0.91
Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients. PLoS One (2010) 0.85
Progress in multiple sclerosis genetics. Curr Genomics (2012) 0.81
Analysis of HLA DR2&DQ6 (DRB1*1501, DQA1*0102, DQB1*0602) haplotypes in Iranian patients with multiple sclerosis. Cell Mol Neurobiol (2008) 0.80
The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania. BMC Neurol (2013) 0.78
Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis. JAMA Neurol (2016) 0.77
Genetic determinants of risk and progression in multiple sclerosis. Clin Chim Acta (2015) 0.77
Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients. Neurogenetics (2012) 0.76
The intelligent use and clinical benefits of electronic medical records in multiple sclerosis. Expert Rev Clin Immunol (2014) 0.76
HLA class I & II alleles in multiple sclerosis patients from Puerto Rico. Bol Asoc Med P R (2013) 0.75
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology (2005) 3.45
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst (1996) 2.98
Sinistrality--a side-effect of prenatal sonography: a comparative study of young men. Epidemiology (2001) 2.80
Estimation of multivariate frailty models using penalized partial likelihood. Biometrics (2000) 2.70
Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol (1988) 2.53
Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Clin Nutr (1995) 2.25
Association of rheumatoid arthritis with a dominant DR1/Dw4/Dw14 sequence motif, but not with T cell receptor beta chain gene alleles or haplotypes. Arthritis Rheum (1991) 2.20
Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol (2001) 2.11
HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol (2000) 2.05
Cancer risk among patients with multiple sclerosis and their parents. Neurology (2009) 2.03
Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens (2000) 1.82
HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens (1991) 1.80
Shared genetic factors may not explain the raised risk of comorbid inflammatory diseases in multiple sclerosis. Mult Scler (2012) 1.65
CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun (2001) 1.62
Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet (2008) 1.59
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs. Mult Scler (2012) 1.59
Reproducibility and validity of dietary assessment instruments. II. A qualitative food frequency questionnaire. Am J Epidemiol (1988) 1.53
Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease. Genes Immun (2004) 1.53
A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes Immun (2008) 1.47
Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens (2004) 1.47
Prognosis of patients with lung cancer found in a single chest radiograph screening. Chest (1998) 1.44
Maternal smoking during pregnancy and multiple sclerosis amongst offspring. Eur J Neurol (2008) 1.41
Multiple sclerosis in a family on the Faroe Islands. Acta Neurol Scand (2009) 1.38
Neutralizing antibodies against interferon β: fluctuation is modest and titre dependent. Eur J Neurol (2008) 1.37
Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci U S A (1989) 1.36
Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study. Ann Rheum Dis (2009) 1.36
Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden. Eur J Neurol (2001) 1.34
Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun (2005) 1.32
K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location. Br J Cancer (1994) 1.31
The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele. Tissue Antigens (1995) 1.29
Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis. Genes Immun (2005) 1.28
Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings. Neurology (1998) 1.26
Energy transfer in spectrally inhomogeneous light-harvesting pigment-protein complexes of purple bacteria. Biophys J (1995) 1.23
Apoptosis mediators fasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS. Neurology (2000) 1.21
Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLA-DQB1, -DQA1 and -DRB1. Genes Immun (2003) 1.19
Epstein-Barr virus and multiple sclerosis: interaction with HLA. Genes Immun (2011) 1.17
Distribution of HLA class II alleles among Norwegian Caucasians. Hum Immunol (1990) 1.12
Does 77C-->G in PTPRC modify autoimmune disorders linked to the major histocompatibility locus? Nat Genet (2001) 1.11
Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. Tissue Antigens (1991) 1.11
The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis. Genes Immun (2001) 1.11
Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. Neurosci Lett (2000) 1.08
Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15. Eur J Neurol (2012) 1.07
Haemophilus influenzae type b strains of outer membrane subtypes 1 and 1c cause different types of invasive disease. Lancet (1987) 1.05
Blockade of chemokine signaling in patients with multiple sclerosis. Neurology (2006) 1.05
Swedish natalizumab (Tysabri) multiple sclerosis surveillance study. Neurol Sci (2011) 1.05
Variability in nutrient and food intakes among older middle-aged men. Implications for design of epidemiologic and validation studies using food recording. Am J Epidemiol (1990) 1.04
T cell-specific adapter protein inhibits T cell activation by modulating Lck activity. J Immunol (2000) 1.03
Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis. J Neurol Sci (2000) 1.03
Rheumatoid arthritis may be primarily associated with HLA-DR4 molecules sharing a particular sequence at residues 67-74. Tissue Antigens (1990) 1.01
Long-term supplementation with alpha-tocopherol and beta-carotene and age-related cataract. Acta Ophthalmol Scand (1997) 1.01
Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis. Eur J Immunol (1992) 1.01
In-vitro effects of Candida albicans of amphotericin B combined with other antibiotics. Preliminary observations. Scand J Infect Dis Suppl (1976) 1.01
Familial effects on the clinical course of multiple sclerosis. Neurology (2007) 1.00
HLA complex genes in type 1 diabetes and other autoimmune diseases. Which genes are involved? Trends Genet (2001) 1.00
The amino acid at position 57 of the HLA-DQ beta chain and susceptibility to develop insulin-dependent diabetes mellitus. Hum Immunol (1989) 0.99
Hospital admission due to infections in multiple sclerosis patients. Eur J Neurol (2013) 0.99
Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complex. Genes Immun (2009) 0.98
Correcting for non-compliance in randomized trials: an application to the ATBC Study. Stat Med (1999) 0.98
HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry (2002) 0.98
APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers. Neurology (2006) 0.97
Environmental risk factors in multiple sclerosis. Acta Neurol Scand Suppl (2008) 0.97
Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis. Am J Hum Genet (2001) 0.97
Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes. Tissue Antigens (2007) 0.97
Energy migration in the light-harvesting antenna of the photosynthetic bacterium Rhodospirillum rubrum studied by time-resolved excitation annihilation at 77 K. Biophys J (1996) 0.97
The PTPN22 promoter polymorphism -1123G>C association cannot be distinguished from the 1858C>T association in a Norwegian rheumatoid arthritis material. Tissue Antigens (2007) 0.97
EFNS guidelines on the molecular diagnosis of mitochondrial disorders. Eur J Neurol (2009) 0.97
Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis. Genes Immun (2007) 0.96
Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status. Int J Cancer (1996) 0.95
Conditional analyses on the T1DGC MHC dataset: novel associations with type 1 diabetes around HLA-G and confirmation of HLA-B. Genes Immun (2008) 0.95
RGMA and IL21R show association with experimental inflammation and multiple sclerosis. Genes Immun (2010) 0.95
The CTLA-4 gene is associated with multiple sclerosis. J Neuroimmunol (1999) 0.95
Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology (1996) 0.94
HLA-DRB1 and month of birth in multiple sclerosis. Neurology (2009) 0.94
Association study of IL2/IL21 and FcgRIIa: significant association with the IL2/IL21 region in Scandinavian coeliac disease families. Genes Immun (2008) 0.94
A proliferation-inducing ligand (APRIL) is expressed by astrocytes and is increased in multiple sclerosis. Scand J Immunol (2007) 0.93
MGAT5 alters the severity of multiple sclerosis. J Neuroimmunol (2010) 0.93
T cell epitopes encompassing the mutational hot spot position 61 of p21 ras. Promiscuity in ras peptide binding to HLA. Eur J Immunol (1994) 0.93